Stay updated on DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-12-01T17:37:26.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1 on the page. This change represents a backend version update rather than any modification to the study content.
    Difference
    0.0%
    Check dated 2025-11-24T14:35:28.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removed the administrative notice about a lapse in government funding and related operating-status references (cc.nih.gov and opm.gov). This change affects only site housekeeping and does not alter the study details or eligibility information on the page.
    Difference
    0.3%
    Check dated 2025-11-17T06:55:04.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Results were posted for NCT03325101 (Results First Posted 2025-06-12), and the study status was updated to Terminated due to poor accrual.
    Difference
    0.4%
    Check dated 2025-11-03T01:20:25.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    3%
    Check dated 2025-10-05T10:15:32.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Adds Melanoma as a MedlinePlus topic and updates to revision v3.1.0; removes the older Melanoma, Cutaneous Malignant topic and revision v3.0.2.
    Difference
    0.3%
    Check dated 2025-09-28T03:17:17.000Z thumbnail image

Stay in the know with updates to DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.